Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...

Laboratory Corporation of America Holdings LH, popularly known as LabCorp, recently launched the Neurofilament Light Chain (NfL) blood test to facilitate the detection and verification of the signs of ...

Labcorp announced it will begin offering the Elecsys pTau181 blood test nationwide by early 2026, making available the only FDA-cleared blood test in the U.S. to aid in the initial assessment for ...

Labcorp LH recently announced the launch and national availability of its blood biomarker test, Amyloid-Tau-Neurodegeneration (“ATN”) Profile. Physicians can now use the test with patients who are ...

Laboratory Corporation of America Holdings, Inc., or Labcorp LH, recently launched a new, FDA-cleared blood test for risk assessment and clinical management of severe preeclampsia. The preeclampsia is ...

Laboratory Corporation of America Holdings LH, known as LabCorp, recently launched the Labcorp Clinical Decision Support (CDS) interpretative test report for its Stinging Insect Component-Specific IgE ...

LabCorp's at-home test was approved by the FDA fro emergency use Laboratory Corp. of America Holdings (NYSE:LH) is higher this morning after the Food and Drug Administration (FDA) granted emergency ...